Trial Now Recruiting: Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease (NCT02504879)
WHY IT MATTERS
This is an active recruiting trial sponsored by the National Institutes of Health that could help researchers understand melorheostosis progression and identify disease mechanisms, potentially leading to future treatments for this condition with limited research.
Researchers are looking for people with melorheostosis, a rare disease where bones become abnormally thick and hard, to join a study. The study will follow participants over time to understand how the disease develops and what causes it. Doctors will do physical exams and collect medical information from people with the disease and their unaffected family members.
NCT ID: NCT02504879 Status: RECRUITING Conditions: Rheumatic Disease Enrollment: 350 Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Summary: Background: \- The rare disease melorheostosis causes bones to thicken. This may lead to pain, and can affect bones, joints, and muscles. Researchers want to learn more about the disease and how it progresses. Objective: -To see what happens to people with melorheostosis over time and understand the causes of the disease. Eligibility: * People 18 and over with melorheostosis. * Their unaffected relatives. Design: * All participants will have a medical history and physical exam. * Particip
YOU CAN ACT ON THIS
If you have melorheostosis and are 18 or older, you can contact the study team now to learn if you qualify for enrollment at NCT02504879.